Literature DB >> 11421361

Substrate recognition by ADAR1 and ADAR2.

S K Wong1, S Sato, D W Lazinski.   

Abstract

RNA editing catalyzed by ADAR1 and ADAR2 involves the site-specific conversion of adenosine to inosine within imperfectly duplexed RNA. ADAR1- and ADAR2-mediated editing occurs within transcripts of glutamate receptors (GluR) in the brain and in hepatitis delta virus (HDV) RNA in the liver. Although the Q/R site within the GluR-B premessage is edited more efficiently by ADAR2 than it is by ADAR1, the converse is true for the +60 site within this same transcript. ADAR1 and ADAR2 are homologs having two common functional regions, an N-terminal double-stranded RNA-binding domain and a C-terminal deaminase domain. It is neither understood why only certain adenosines within a substrate molecule serve as targets for ADARs, nor is it known which domain of an ADAR confers its specificity for particular editing sites. To assess the importance of several aspects of RNA sequence and structure on editing, we evaluated 20 different mutated substrates, derived from four editing sites, for their ability to be edited by either ADAR1 or ADAR2. We found that when these derivatives contained an A:C mismatch at the editing site, editing by both ADARs was enhanced compared to when A:A or A:G mismatches or A:U base pairs occurred at the same site. Hence substrate recognition and/or catalysis by ADARs could involve the base that opposes the edited adenosine. In addition, by using protein chimeras in which the deaminase domains were exchanged between ADAR1 and ADAR2, we found that this domain played a dominant role in defining the substrate specificity of the resulting enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421361      PMCID: PMC1370134          DOI: 10.1017/s135583820101007x

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  34 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

2.  Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase.

Authors:  Y Liu; C X George; J B Patterson; C E Samuel
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

3.  Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase.

Authors:  Y Liu; C E Samuel
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  The importance of internal loops within RNA substrates of ADAR1.

Authors:  K A Lehmann; B L Bass
Journal:  J Mol Biol       Date:  1999-08-06       Impact factor: 5.469

5.  Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes.

Authors:  S Maas; A P Gerber; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  An adenosine deaminase that generates inosine at the wobble position of tRNAs.

Authors:  A P Gerber; W Keller
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

7.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing.

Authors:  C M Burns; H Chu; S M Rueter; L K Hutchinson; H Canton; E Sanders-Bush; R B Emeson
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  RED2, a brain-specific member of the RNA-specific adenosine deaminase family.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; M Higuchi; P H Seeburg
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

9.  Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.

Authors:  A Gerber; H Grosjean; T Melcher; W Keller
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

10.  Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.

Authors:  S Maas; T Melcher; A Herb; P H Seeburg; W Keller; S Krause; M Higuchi; M A O'Connell
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

View more
  104 in total

1.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm.

Authors:  Swee Kee Wong; Shuji Sato; David W Lazinski
Journal:  RNA       Date:  2003-05       Impact factor: 4.942

4.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

5.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  A survey of RNA editing in human brain.

Authors:  Matthew Blow; P Andrew Futreal; Richard Wooster; Michael R Stratton
Journal:  Genome Res       Date:  2004-11-15       Impact factor: 9.043

Review 7.  Biological significance of RNA editing in cells.

Authors:  Wei Tang; Yongjun Fei; Michael Page
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

Review 8.  Substitutional A-to-I RNA editing.

Authors:  Bjorn-Erik Wulff; Kazuko Nishikura
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Jul-Aug       Impact factor: 9.957

9.  Genome, Epigenome, and Transcriptome Editing via Chemical Modification of Nucleobases in Living Cells.

Authors:  Brodie L Ranzau; Alexis C Komor
Journal:  Biochemistry       Date:  2018-12-12       Impact factor: 3.162

Review 10.  Current strategies for Site-Directed RNA Editing using ADARs.

Authors:  Maria Fernanda Montiel-Gonzalez; Juan Felipe Diaz Quiroz; Joshua J C Rosenthal
Journal:  Methods       Date:  2018-11-29       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.